project id: TCGA-READ; case submitter id: TCGA-AF-A56L; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; concentration: 0.15; normal tumor genotype snp match: Yes; age at index: 48; days to birth: -17734; ethnicity: not reported; gender: female; race: black or african american; vital status: Alive; year of birth: 1960; age at diagnosis: 17734; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIC; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2007.0; icd 10 code: C19; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Rectosigmoid junction; synchronous malignancy: No; tissue or organ of origin: Rectosigmoid junction; tumor grade: Not Reported; year of diagnosis: 2008; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1685; days to sample procurement: 0; initial weight: 550.0; portion submitter id: TCGA-AF-A56L-01A-31; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 3.0; percent neutrophil infiltration: 1.0; percent normal cells: 12.0; percent stromal cells: 0.0; percent tumor cells: 85.0; percent tumor nuclei: 60.0;